Luis B. Agellon

12.0k citations
150 papers · 9.4k indexed · 4 hit papers · h-index 46
Topics
Drug Transport and Resistance Mechanisms (36 papers)Cholesterol and Lipid Metabolism (32 papers)Peroxisome Proliferator-Activated Receptors (27 papers)

In The Last Decade

Luis B. Agellon

149 papers receiving 9.2k citations

Hit Papers

MicrobiomeAnalyst: a...199020262002201420171990200620154008001.2k

Peers

Luis B. Agellon
Comparison fields: 5 of 162
  • Molecular Biology 4.1k
  • Surgery 2.9k
  • Endocrinology, Diabetes and Metabolism 1.7k
  • Epidemiology 1.4k
  • Oncology 1.2k
Replace Hans‐Georg Joost with:
Hans‐Georg Joost Germany
Philippe Lefèbvre France
Beverly Paigen United States
Akira Yoshida Japan
William S. Blaner United States
Gerhard Liebisch Germany
Peter J. Meikle Australia
Brian N. Finck United States
Takayuki Matsumoto Japan
Yu Li China
Luis B. Agellon relative to Hans‐Georg Joost Germany Hans‐Georg Joost's profile →
Citations per field
00.5×1.5×2.0×
Hans‐Georg Joost · 1×
Citations per year

Countries citing papers authored by Luis B. Agellon

Since Specialization
Citations

This map shows the geographic impact of Luis B. Agellon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis B. Agellon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis B. Agellon more than expected).

Fields of papers citing papers by Luis B. Agellon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luis B. Agellon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis B. Agellon. The network helps show where Luis B. Agellon may publish in the future.

Co-authorship network of co-authors of Luis B. Agellon

This figure shows the co-authorship network connecting the top 25 collaborators of Luis B. Agellon. A scholar is included among the top collaborators of Luis B. Agellon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luis B. Agellon. Luis B. Agellon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 1
3 30
4 10
5 2
6 15
7 13
8 40
9 15
10
The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitisbreakdown →
576
11 27
12 80
13 5
14 38
15 45
16 56
17 5
18 108
19 30
20 96

About Luis B. Agellon

Luis B. Agellon is a scholar working on Cell Biology, Oncology and Biochemistry, having authored 150 papers that have together received 9.4k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (36 papers), Cholesterol and Lipid Metabolism (32 papers) and Peroxisome Proliferator-Activated Receptors (27 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.7k citations), Biochemistry (641 citations) and Cell Biology (1.2k citations). Luis B. Agellon has collaborated with scholars based in Canada, United States and Netherlands. Frequent co-authors include Marek Michalak, Alan R. Tall, Dennis E. Vance, Salam M. Habib, Jianguo Xia, Jasmine Chong, Achal Dhariwal, Irah L. King, Jody Groenendyk and Joachim Krebs. Their work appears in journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026